NASS 2019 Annual Meeting

Abstract Presentations: Spinal Deformity III (Room Room W470b)

Moderator: Robert F. McLain, MD

 

187. The impact of the lower instrumented level on outcomes in cervical deformity surgery
Peter G. Passias, MD1; Haddy Alas, BS2; Avery Brown, BS2; Katherine E. Pierce, BS3; Cole Bortz, BA3; Renaud Lafage, MSc4; Virginie Lafage, PhD4; Bassel G. Diebo, MD5
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3New York, NY, US; 4Hospital for Special Surgery, New York, NY, US; 5Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

188. 'Soft landing': can hooks at the upper instrumented level prevent proximal junctional kyphosis and proximal junctional failure in adult spinal deformity?
Nissim Ackshota, MD1; Comron Saifi, MD2; Rikesh Gandhi; Muhammad B. Janjua, MD3; Sajeel R. Khan, MD4; Vincent Arlet, MD1
1Pennsylvania Hospital/Shriners Hospitals for Children, Philadelphia, PA, US; 2William Dyson, Philadelphia, PA, US; 3Dallas, TX, US; 4Philadelphia, PA, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

189. A data-driven approach to assessment of sagittal alignment: defining the spinopelvic ratio’s impact on clinical outcomes in adult spinal deformity patients
Wesley Durand, BS1; Alan H. Daniels, MD2; D. Kojo Hamilton, MD3; Peter G. Passias, MD4; Han Jo Kim, MD5; Themistocles S. Protopsaltis, MD6; Virginie Lafage, PhD5; Renaud Lafage, MSc5; Justin S. Smith, MD, PhD7; Christopher I. Shaffrey, MD8; Munish C. Gupta, MD9; Eric O. Klineberg, MD10; Frank J. Schwab, MD5; Douglas C. Burton, MD11; Shay Bess, MD12; Christopher P. Ames, MD13; Robert A. Hart, MD14; International Spine Study Group15
1Brown University, Alpert Medical School, Providence, RI, US; 2Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US; 3University of Pittsburgh School of Medicine, Pittsburgh, PA, US; 4NY Spine Institute, NYU Langone Health, New York, NY, US; 5Hospital for Special Surgery, New York, NY, US; 6Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 7UVA Health System, Charlottesville, VA, US; 8University of Virginia, Charlottesville, VA, US; 9Washington University School of Medicine, St. Louis, MO, US; 10UC, Davis School of Medicine, Sacramento, CA, US; 11University of Kansas Medical Center, Kansas City, KS, US; 12Denver, CO, US; 13University of California, San Francisco, San Francisco, CA, US; 14Swedish Neuroscience Institute, Seattle, WA, US; 15Brighton, CO, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

190. Preoperative opioid therapy poorly controls pain in non-revision adult spinal deformity (ASD) and increases risk for chronic postoperative opioid usage
Shay Bess, MD1; Breton Line, BS2; Michael P. Kelly, MD3; Jeffrey L. Gum, MD4; Richard A. Hostin Jr., MD5; Khaled M. Kebaish, MD6; Christopher P. Ames, MD7; Douglas C. Burton, MD8; Gregory M. Mundis Jr., MD9; Robert K. Eastlack, MD10; Robert A. Hart, MD11; Munish C. Gupta, MD12; Eric O. Klineberg, MD13; Han Jo Kim, MD14; Virginie Lafage, PhD14; Renaud Lafage, MSc14; Alexandra Soroceanu, MD, MPH15; Frank J. Schwab, MD14; Christopher I. Shaffrey, MD16; Justin S. Smith, MD, PhD17; International Spine Study Group18
1Denver, CO, US; 2Denver International Spine Center, Denver, CO, US; 3Washington University, Saint Louis, MO, US; 4Norton Leatherman Spine Center, Louisville, KY, US; 5Southwest Scoliosis Institute, Plano, TX, US; 6Johns Hopkins University, Baltimore, MD, US; 7University of California, San Francisco, San Francisco, CA, US; 8University of Kansas Medical Center, Kansas City, KS, US; 9Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 10Scripps Clinic, San Diego, CA, US; 11Swedish Neuroscience Institute, Seattle, WA, US; 12Washington University School of Medicine, St. Louis, MO, US; 13UC, Davis School of Medicine, Sacramento, CA, US; 14Hospital for Special Surgery, New York, NY, US; 15University of Calgary, Calgary, Canada; 16University of Virginia, Charlottesville, VA, US; 17UVA Health System, Charlottesville, VA, US; 18Brighton, CO, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion

 

191. Operative treatment for thoracic adult scheuermann kyphosis: preoperative disability and surgical outcomes
Shay Bess, MD1; Breton Line, BS2; Christopher P. Ames, MD3; Douglas C. Burton, MD4; Richard A. Hostin Jr., MD5; Gregory M. Mundis Jr., MD6; Robert K. Eastlack, MD7; Robert A. Hart, MD8; Munish C. Gupta, MD9; Michael P. Kelly, MD10; Virginie Lafage, PhD11; Eric O. Klineberg, MD12; Khaled M. Kebaish, MD13; Han Jo Kim, MD11; Frank J. Schwab, MD11; Christopher I. Shaffrey, MD14; Justin S. Smith, MD, PhD15; International Spine Study Group16
1Denver, CO, US; 2Denver International Spine Center, Denver, CO, US; 3University of California, San Francisco, San Francisco, CA, US; 4University of Kansas Medical Center, Kansas City, KS, US; 5Southwest Scoliosis Institute, Plano, TX, US; 6Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 7Scripps Clinic, San Diego, CA, US; 8Swedish Neuroscience Institute, Seattle, WA, US; 9Washington University School of Medicine, St. Louis, MO, US; 10Washington University, Saint Louis, MO, US; 11Hospital for Special Surgery, New York, NY, US; 12UC, Davis School of Medicine, Sacramento, CA, US; 13Johns Hopkins University, Baltimore, MD, US; 14University of Virginia, Charlottesville, VA, US; 15UVA Health System, Charlottesville, VA, US; 16Brighton, CO, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

192. Use of BMP for adult spinal deformity surgery: patterns of usage and changes over the past decade
Mathieu Bannwarth, MD1; Justin S. Smith, MD, PhD2; Shay Bess, MD3; Eric O. Klineberg, MD4; Christopher P. Ames, MD5; Robert A. Hart, MD6; Gregory M. Mundis Jr., MD7; Han Jo Kim, MD1; Renaud Lafage, MSc1; Munish C. Gupta, MD8; Douglas C. Burton, MD9; Christopher I. Shaffrey, MD10; Frank J. Schwab, MD1; Virginie Lafage, PhD1; International Spine Study Group11
1Hospital for Special Surgery, New York, NY, US; 2UVA Health System, Charlottesville, VA, US; 3Denver, CO, US; 4UC, Davis School of Medicine, Sacramento, CA, US; 5University of California, San Francisco, San Francisco, CA, US; 6Swedish Neuroscience Institute, Seattle, WA, US; 7Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 8Washington University School of Medicine, St. Louis, MO, US; 9University of Kansas Medical Center, Kansas City, KS, US; 10University of Virginia, Charlottesville, VA, US; 11Brighton, CO, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

193. Comprehensive alignment planning (CAP) for adult spinal deformity (ASD) more effectively predicts surgical outcomes and proximal junctional kyphosis than previous classifications
Renaud Lafage, MSc1; Justin S. Smith, MD, PhD2; Jonathan Elysee1; Peter G. Passias, MD3; Shay Bess, MD4; Eric O. Klineberg, MD5; Han Jo Kim, MD1; Christopher I. Shaffrey, MD6; Douglas C. Burton, MD7; Richard A. Hostin Jr., MD8; Gregory M. Mundis Jr., MD9; Christopher P. Ames, MD10; Frank J. Schwab, MD1; Virginie Lafage, PhD1; International Spine Study Group11
1Hospital for Special Surgery, New York, NY, US; 2UVA Health System, Charlottesville, VA, US; 3NY Spine Institute, NYU Langone Health, New York, NY, US; 4Denver, CO, US; 5UC, Davis School of Medicine, Sacramento, CA, US; 6University of Virginia, Charlottesville, VA, US; 7University of Kansas Medical Center, Kansas City, KS, US; 8Southwest Scoliosis Institute, Plano, TX, US; 9Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 10University of California, San Francisco, San Francisco, CA, US; 11Brighton, CO, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

194. Outcomes of surgical treatment for 138 patients with severe sagittal deformity at a minimum two-year follow up
Justin K. Scheer, MD1; Lawrence G. Lenke, MD2; Justin S. Smith, MD, PhD3; Peter G. Passias, MD4; Han Jo Kim, MD5; Shay Bess, MD6; Themistocles S. Protopsaltis, MD7; Douglas C. Burton, MD8; Eric O. Klineberg, MD9; Virginie Lafage, PhD5; Frank J. Schwab, MD5; Christopher I. Shaffrey, MD10; Christopher P. Ames, MD1; International Spine Study Group11
1University of California, San Francisco, San Francisco, CA, US; 2, New York, NY, US; 3UVA Health System, Charlottesville, VA, US; 4NY Spine Institute, NYU Langone Health, New York, NY, US; 5Hospital for Special Surgery, New York, NY, US; 6, Denver, CO, US; 7Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 8University of Kansas Medical Center, Kansas City, KS, US; 9UC, Davis School of Medicine, Sacramento, CA, US; 10University of Virginia, Charlottesville, VA, US; 11, Brighton, CO, US>

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

195. Residual curve and truncal shift impact patient satisfaction after surgery for AIS
Majd Marrache, MD1; Paul D. Sponseller, MD1; Baron S. Lonner, MD2; Aaron J. Buckland, MBBS, FRACS3; Michael P. Kelly, MD4; Suken A. Shah, MD5; Michelle C. Marks, PT6; Amit Jain, MD7
12Mount Sinai Beth Israel Medical Center, New York, NY, US; 3Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 4Washington University, Saint Louis, MO, US; 5DuPont Hospital for Children, Wilmington, DE, US; 6Setting Scoliosis Straight, San Diego, CA, US; 7Dept of Orthopaedic Surgery, Baltimore, MD, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

196. Longitudinal changes of the sagittal plane after posterior spinal fusion of adolescent idiopathic scoliosis in Lenke 5 and 6 from baseline to two-year follow up
Mostafa H. El Dafrawy, MD1; Owoicho Adogwa, MD, MPH2; Michael P. Kelly, MD3; Suken A. Shah, MD4; Randal R. Betz, MD5; Lawrence G. Lenke, MD6; Michelle C. Marks, PT7; Daniel J. Sucato, MD8; Harry L. Shufflebarger, MD9; Munish C. Gupta, MD10
1The Johns Hopkins Hospital, Baltimore, MD, US; 2Saint Louis, MO, US; 3Washington University, Saint Louis, MO, US; 4DuPont Hospital for Children, Wilmington, DE, US; 5Institute for Spine and Scoliosis, Lawrenceville, NJ, US; 6New York, NY, US; 7Setting Scoliosis Straight, San Diego, CA, US; 8Texas Scottish Rite Hospital for Children, Dallas, TX, US; 9Miami Childrens Hospital, Miami, FL, US; 10Washington University School of Medicine, St. Louis, MO, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion